Leonie Scholz

Asklepios Klinik St. Georg

Papers

2

Total Citations

43

H-Index

2

About

Dr. Leonie Scholz is a leading clinical researcher in cardiac electrophysiology, with a focused expertise in the comparative effectiveness of catheter ablation technologies for atrial fibrillation (AF). Her seminal work centers on evaluating robotic versus manual catheter ablation techniques, a critical area for improving procedural precision and patient outcomes in AF treatment. Dr. Scholz’s most influential contribution is the "Man and Machine Trial," a landmark investigation that rigorously compared circumferential pulmonary vein isolation (CPVI) using irrigated radiofrequency ablation performed manually versus with robotic assistance. Her 2017 publication, *Manual Versus Robotic Catheter Ablation for the Treatment of Atrial Fibrillation*, has garnered 32 citations, establishing a foundational reference for clinicians and researchers debating the adoption of robotic systems. This work addresses a key clinical question: whether robotic assistance enhances the efficacy and safety of CPVI, the most common ablation technique for AF worldwide. By providing evidence from one of the first large, randomized multicenter trials in this domain, Dr. Scholz has directly informed clinical guidelines and technological adoption. Her research is indispensable for cardiologists and biomedical engineers seeking to optimize ablation strategies and improve long-term outcomes for the millions of patients living with atrial fibrillation.

Research Focus

Key Achievements

2
H-Index
2
Papers
43
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Manual Versus Robotic Catheter Ablation for the Treatment of Atrial Fibrillation
32 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Asklepios Klinik St. Georg

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago